Skip to content
← Back to this collection

PUBLICATIONS · 18413638

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2008 May 20
First author
Horwitz EM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Horwitz EM
      type
      Author
    2. name
      Bae K
      type
      Author
    3. name
      Hanks GE
      type
      Author
    4. name
      Porter A
      type
      Author
    5. name
      Grignon DJ
      type
      Author
    6. name
      Brereton HD
      type
      Author
    7. name
      Venkatesan V
      type
      Author
    8. name
      Lawton CA
      type
      Author
    9. name
      Rosenthal SA
      type
      Author
    10. name
      Sandler HM
      type
      Author
    11. name
      Shipley WU
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Horwitz EM
      type
      Author
    2. name
      Bae K
      type
      Author
    3. name
      Hanks GE
      type
      Author
    4. name
      Porter A
      type
      Author
    5. name
      Grignon DJ
      type
      Author
    6. name
      Brereton HD
      type
      Author
    7. name
      Venkatesan V
      type
      Author
    8. name
      Lawton CA
      type
      Author
    9. name
      Rosenthal SA
      type
      Author
    10. name
      Sandler HM
      type
      Author
    11. name
      Shipley WU
      type
      Author
    bibliography ids
    1. nci-bib-306fe47aa99e72225bf64dd5
    book metadata
    content sha256
    862d5544377c5d057356c40c0bb1d67a2d46f68ae2b2cdd46d19f9c9c06065b3
    document type
    citation
    dois
    1. 10.1200/JCO.2007.14.9021
    electronic publication date
    display
    2008 Apr 14
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18413638
    immutable id
    pubmed:18413638@862d5544377c5d057356c40c0bb1d67a2d46f68ae2b2cdd46d19f9c9c06065b3
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    15
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    2497-504
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18413638
      provenance
      batch id
      e663b4be92ee60a9b059
      provider
      NCBI PubMed ESummary
      record sha256
      ffd14099da214c3feae1087ae1f718849b85ca9169b572a1446b4f7fab7ac590
      response sha256
      514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
      retrieved at
      2026-09-09T23:46:19.265979+00:00
      publication date
      display
      2008 May 20
      precision
      day
      year
      2008
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18413638/
      title
      Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.

      Preserved source evidence · Not medical advice